查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598769

單位劑量製造市場：按產品、來源和最終用戶分類 - 全球預測 2025-2030

Unit Dose Manufacturing Market by Product (Liquid Unit Dose, Solid Unit Dose), Sourcing (In-House, Outsourcing), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年單位劑量製造市場價值為233.4億美元，預計到2024年將達到276.1億美元，複合年成長率為18.76%，到2030年將達到778.1億美元。

單位劑量生產涉及生產單獨的、預先測量的藥物劑量，已成為醫療保健和製藥行業不可或缺的一部分。對有效藥物管理、病人安全和遵守處方治療方法的需求日益成長，尤其是在醫院和長期照護機構中，這一需求更加突出。應用範圍不僅限於藥品，還包括營養食品和非處方藥，其中使用單位劑量來提高準確性和安全性。最終使用領域包括醫院、家庭保健、藥局等。影響市場成長的關鍵因素包括慢性病的增加、遵守藥品分銷法規、減少用藥錯誤。家庭醫療保健服務的上升趨勢和自動化單位劑量包裝技術的進步為市場提供了潛在的機會。特別是，智慧包裝和自動分配系統的創新是投資成熟的領域。然而，市場面臨初始實施成本高昂和需要嚴格合規的複雜監管環境等限制。此外，整合先進技術需要熟練的人員，鑑於專業醫療保健領域的勞動力差異，這可能是一項艱鉅的挑戰。創新和研究應著重於開發具有成本效益和高效的包裝解決方案，並整合數位健康技術以增強藥物依從性追蹤和監控。市場競爭激烈，各公司競相增強技術力並擴大服務組合。未來的成長路徑包括個人化醫療和促進即時資料分析的技術，以實現更好的庫存管理和患者治療效果。對於在單位劑量製造業尋求資金的公司來說，永續包裝可以使產品與新興行業趨勢保持一致，注重監管靈活性，並滿足行業標準和消費者期望。

主要市場統計
基準年[2023] 233.4億美元
預測年份 [2024] 276.1億美元
預測年份 [2030] 778.1億美元
複合年成長率（%） 18.76%

市場動態：快速發展的單位劑量製造市場的關鍵市場洞察

供需的動態交互作用正在改變單位劑量製造市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 增加採用單位劑量以減少用藥錯誤
    • 人們越來越認知到單位劑量製造優於重新包裝
    • 醫藥工業快速發展
  • 市場限制因素
    • 原物料價格波動
  • 市場機會
    • 創新的包裝技術和交付解決方案
    • 採用固態劑型的連續生產（CM）
  • 市場挑戰
    • 與採用生產單位劑量相關的問題

波特五力：駕馭單位劑量製造市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解單位劑量製造市場的外部影響

外部宏觀環境因素在塑造單位劑量製造市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解單位劑量製造市場的競爭格局

單位劑量製造市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣單位劑量製造市場供應商的績效評估

FPNV定位矩陣是評估單位劑量製造市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製單位劑量製造市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，單位劑量製造市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加單位劑量的採用以減少用藥錯誤
      • 提高人們對單位劑量生產相對於重新包裝的優勢的認知
      • 醫藥工業快速發展
    • 抑制因素
      • 原物料價格波動
    • 機會
      • 創新的包裝技術與運輸解決方案
      • 採用固態劑型的連續生產（CM）
    • 任務
      • 與採用製造單位劑量相關的問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章單位劑量製造市場：依產品

  • 液體單位劑量
  • 固態單位劑量

第7章單位劑量製造市場（按採購）

  • 公司內部
  • 外包

第8章單位劑量製造市場：依最終用戶分類

  • 醫院
  • 獨立藥房
  • 長期照護設施

第9章美洲單位劑量製造市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太單位劑量製造市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲單位劑量製造市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amcor PLC
  • American Health Packaging
  • Catalent Inc.
  • Cencora, Inc.
  • Corden Pharma GmbH
  • Medical Packaging Inc., LLC
  • Mikart, LLC
  • Patheon by Thermo Fisher Scientific Inc.
  • The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • Unither Pharmaceuticals SAS
Product Code: MRR-3A2E844FDFFA

The Unit Dose Manufacturing Market was valued at USD 23.34 billion in 2023, expected to reach USD 27.61 billion in 2024, and is projected to grow at a CAGR of 18.76%, to USD 77.81 billion by 2030.

Unit Dose Manufacturing involves the production of pre-measured, individualized doses of medications and is a vital component within the healthcare and pharmaceutical industries. Its necessity is emphasized by the growing demand for effective medication management, patient safety, and adherence to prescribed therapies, especially in hospitals and long-term care facilities. Applications extend beyond pharmaceuticals into nutraceuticals and over-the-counter medications, leveraging unit doses for precision and safety. End-use sectors include hospitals, home healthcare, and pharmacies. Key factors influencing market growth include increasing chronic disease prevalence, regulatory compliance for medication distribution, and the push for reduced medication errors. The growing trend of home healthcare services and the advancement of automated unit dose packaging technologies present potential opportunities for the market. Notably, technological innovations in smart packaging and automated dispensing systems are areas ripe for investment. However, the market faces limitations such as high initial implementation costs and a complex regulatory landscape that demands rigorous adherence. Moreover, the integration of advanced technologies requires skilled personnel, which can be a challenging factor given the workforce gap in specialized healthcare domains. Innovation and research should focus on developing cost-effective, efficient packaging solutions and integrating digital health technologies that enhance tracking and monitoring of medication adherence. The market's nature is competitive, with companies vying to enhance their technological capabilities and expand their service portfolios. Future growth avenues may include personalized medicine and technologies that facilitate real-time data analytics for better inventory management and patient outcomes. For companies aiming to capitalize on the unit dose manufacturing industry, it is critical to align product offerings with emerging industry trends, focus on regulatory agility, and invest in sustainable packaging solutions that meet both industry standards and consumer expectations.

KEY MARKET STATISTICS
Base Year [2023] USD 23.34 billion
Estimated Year [2024] USD 27.61 billion
Forecast Year [2030] USD 77.81 billion
CAGR (%) 18.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Unit Dose Manufacturing Market

The Unit Dose Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of unit doses to reduce medication errors
    • Rising awareness of benefits of manufacturing unit doses over repackaging
    • Rapid development in the pharmaceutical industry
  • Market Restraints
    • Fluctuations in the prices of raw materials
  • Market Opportunities
    • Innovative packaging technologies and delivery solutions
    • Adopting continuous manufacturing (CM) for solid-dose drug products
  • Market Challenges
    • Issues associated with the adoption of manufactured unit doses

Porter's Five Forces: A Strategic Tool for Navigating the Unit Dose Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Unit Dose Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Unit Dose Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Unit Dose Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Unit Dose Manufacturing Market

A detailed market share analysis in the Unit Dose Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Unit Dose Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Unit Dose Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Unit Dose Manufacturing Market

A strategic analysis of the Unit Dose Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Unit Dose Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, American Health Packaging, Catalent Inc., Cencora, Inc., Corden Pharma GmbH, Medical Packaging Inc., LLC, Mikart, LLC, Patheon by Thermo Fisher Scientific Inc., The Tapemark Company by LTS Lohmann Therapie-Systeme AG, and Unither Pharmaceuticals SAS.

Market Segmentation & Coverage

This research report categorizes the Unit Dose Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose.
  • Based on Sourcing, market is studied across In-House and Outsourcing.
  • Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
      • 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
      • 5.1.1.3. Rapid development in the pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in the prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative packaging technologies and delivery solutions
      • 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the adoption of manufactured unit doses
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Unit Dose Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Unit Dose
  • 6.3. Solid Unit Dose

7. Unit Dose Manufacturing Market, by Sourcing

  • 7.1. Introduction
  • 7.2. In-House
  • 7.3. Outsourcing

8. Unit Dose Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Pharmacies
  • 8.4. Long Term Care Facility

9. Americas Unit Dose Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Unit Dose Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Unit Dose Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor PLC
  • 2. American Health Packaging
  • 3. Catalent Inc.
  • 4. Cencora, Inc.
  • 5. Corden Pharma GmbH
  • 6. Medical Packaging Inc., LLC
  • 7. Mikart, LLC
  • 8. Patheon by Thermo Fisher Scientific Inc.
  • 9. The Tapemark Company by LTS Lohmann Therapie-Systeme AG
  • 10. Unither Pharmaceuticals SAS

LIST OF FIGURES

  • FIGURE 1. UNIT DOSE MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. UNIT DOSE MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UNIT DOSE MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UNIT DOSE MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LIQUID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOLID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LONG TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023